Wall Street Loves FIGS—Why Do Price Targets Predict Pullback?

Core Insights - FIGS, Inc. has experienced a significant recovery in its stock price, trading above $17, marking a nearly 260% increase over the past year, with a notable 58% rise in the last month [3][8] - Despite the positive stock performance, the consensus 12-month price target is $12.25, indicating a potential decline of almost 30% from current levels, raising questions about the sustainability of this recovery [4][8] Company Performance - The company saw a dramatic decline in stock price post-IPO, dropping below $8 within a year after debuting at $22 per share in May 2021 and reaching $50 shortly after [4][5] - Recent earnings reports have shown strong revenue growth, with Q3 2025 results leading to a stock surge of over 30% following an upbeat outlook and raised guidance for net revenue and adjusted EBITDA margins [6] - The Q4 2025 earnings report revealed a record revenue of over $200 million, a 33% increase year-over-year, with scrubwear sales up 35% and international sales increasing by 55% [7][8] Market Context - The COVID-19 pandemic initially boosted demand for medical apparel, but the stock faced challenges as the pandemic eased, leading to a prolonged period of low trading prices [5] - The recent rally in FIGS stock has been supported by strong earnings and positive analyst sentiment, with Zacks Research upgrading the stock to Strong Buy from Hold [6]